These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3372010)

  • 1. Monoclonal antibodies against human recombinant tumor necrosis factor: prevention of endotoxic shock.
    Shimamoto Y; Chen RL; Bollon A; Chang A; Khan A
    Immunol Lett; 1988 Apr; 17(4):311-7. PubMed ID: 3372010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
    Sheehan KC; Ruddle NH; Schreiber RD
    J Immunol; 1989 Jun; 142(11):3884-93. PubMed ID: 2469726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.
    Smith SR; Terminelli C; Kenworthy-Bott L; Calzetta A; Donkin J
    J Leukoc Biol; 1994 Jun; 55(6):711-8. PubMed ID: 8195696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
    Ashkenazi A; Marsters SA; Capon DJ; Chamow SM; Figari IS; Pennica D; Goeddel DV; Palladino MA; Smith DH
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10535-9. PubMed ID: 1660140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha).
    McLaughlin PJ; Elwood NJ; Russell SM; Andrew SM; McKenzie IF
    Anticancer Res; 1992; 12(4):1243-6. PubMed ID: 1503416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of monoclonal antibodies against recombinant human tumor necrosis factor alpha.
    Li Y; Zhao WW; Shen BF; Sun YX; Wang WX
    Chin J Biotechnol; 1991; 7(2):121-6. PubMed ID: 1806022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody.
    Jin H; Yang R; Marsters SA; Bunting SA; Wurm FM; Chamow SM; Ashkenazi A
    J Infect Dis; 1994 Nov; 170(5):1323-6. PubMed ID: 7963738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock.
    Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P
    Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four epitopes on tumor necrosis factor-alpha defined by murine anti-tumor necrosis factor-alpha monoclonal antibodies.
    Karim B; Béliard R; Huart JJ; Bourel D
    Immunol Lett; 1994 Jul; 41(2-3):139-45. PubMed ID: 8002029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipid A- and lipopolysaccharide-induced cytokine secretion, B cell mitogenesis, and lethal shock by lipid A-specific murine monoclonal antibodies.
    Ramachandra RN; Berczi A; Sehon AH; Berczi I
    J Infect Dis; 1993 May; 167(5):1151-9. PubMed ID: 8486948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production.
    Greeneltch KM; Haudenschild CC; Keegan AD; Shi Y
    Brain Behav Immun; 2004 Sep; 18(5):476-84. PubMed ID: 15265541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and neutralization of bovine tumor necrosis factor by a monoclonal antibody.
    Sileghem M; Saya R; Ellis JA; Flynn JN; Peel JE; Williams DJ
    Hybridoma; 1992 Oct; 11(5):617-27. PubMed ID: 1459585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to human tumor necrosis factor alpha: in vitro and in vivo application.
    Möller A; Emling F; Blohm D; Schlick E; Schollmeier K
    Cytokine; 1990 May; 2(3):162-9. PubMed ID: 1716486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
    Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
    MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock.
    Conrad U; Plagmann I; Malchow S; Sack M; Floss DM; Kruglov AA; Nedospasov SA; Rose-John S; Scheller J
    Plant Biotechnol J; 2011 Jan; 9(1):22-31. PubMed ID: 20444206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
    Feng MH; Cui JC; Nakane A; Hu DL
    Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-tumor necrosis factor (TNF) antibodies protect mouse and human cells from TNF cytotoxicity.
    Galloway CJ; Madanat MS; Mitra G
    J Immunol Methods; 1991 Jun; 140(1):37-43. PubMed ID: 2061612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
    Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
    Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
    Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
    Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody.
    Corti A; Bagnasco L; Cassani G
    Lymphokine Cytokine Res; 1994 Jun; 13(3):183-90. PubMed ID: 7524695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.